Brazil Biobank Market Size & Outlook, 2026-2033

The biobank market in Brazil is expected to reach a projected revenue of US$ 3,570.5 million by 2033. A compound annual growth rate of 7.5% is expected of Brazil biobank market from 2026 to 2033.
Revenue, 2025 (US$M)
$2,013.8
Forecast, 2033 (US$M)
$3,570.5
CAGR, 2026 - 2033
7.5%
Report Coverage
Brazil

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Brazil biobank market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Brazil biobank market highlights

  • The Brazil biobank market generated a revenue of USD 2,013.8 million in 2025 and is expected to reach USD 3,570.5 million by 2033.
  • The Brazil market is expected to grow at a CAGR of 7.5% from 2026 to 2033.
  • In terms of segment, services was the largest revenue generating product & services in 2025.
  • Services is the most lucrative product & services segment registering the fastest growth during the forecast period.


Biobank market data book summary

Market revenue in 2025USD 2,013.8 million
Market revenue in 2033USD 3,570.5 million
Growth rate7.5% (CAGR from 2026 to 2033)
Largest segmentServices
Fastest growing segmentServices
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationProduct, Services
Key market players worldwideThermo Fisher Scientific Inc, Merck KGaA, Qiagen NV, Booz Allen Hamilton Holding Corp Class A, Tecan Group AG, Danaher Corp, Becton Dickinson & Co, Taylor-Wharton, Charles River Laboratories International Inc, Lonza Group Ltd, STEMCELL Technologies, PromoCell GmbH


Other key industry trends

  • In terms of revenue, Brazil accounted for 2.3% of the global biobank market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Latin America, Brazil biobank market is projected to lead the regional market in terms of revenue in 2033.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 3,570.5 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biobank Market Companies

Name Profile # Employees HQ Website
Booz Allen Hamilton Holding Corp Class A View profile 34200 8283 Greensboro Drive, Hamilton Building, McLean, VA, United States, 22102 https://www.boozallen.com
STEMCELL Technologies View profile 501-1000 Vancouver, British Columbia, Canada, North America https://www.stemcell.com
Taylor-Wharton View profile 251-500 Baytown, Texas, United States, North America https://twcryo.com
PromoCell GmbH View profile 51-100 Heidelberg, Baden-Wurttemberg, Germany, Europe http://www.promocell.com/
Tecan Group AG View profile 3591 Seestrasse 103, Mannedorf, Switzerland, 8708 https://www.tecan.com
Charles River Laboratories International Inc View profile 21400 251 Ballardvale Street, Wilmington, MA, United States, 01887 https://www.criver.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Lonza Group Ltd View profile 18000 Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 https://www.lonza.com
Becton Dickinson & Co View profile 73000 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 https://www.bd.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

Brazil biobank market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biobank market will help companies and investors design strategic landscapes.


Services was the largest segment with a revenue share of 89.15% in 2025. Horizon Databook has segmented the Brazil biobank market based on product, services covering the revenue growth of each sub-segment from 2021 to 2033.


Brazil is one of the most economically developed countries in Latin America and its market is expected to grow at a significant rate in the coming years. Moreover, the healthcare sector has been historically driving the Brazilian economy and a strong consumer-based market makes the country. 

An attractive ground for introduction of new products & services in biobanking. Brazil also leads Latin America with the most patent applications and trademark registrations which demonstrates the research and development capabilities of the country. 

The major biobanks players in the country include the Biobank of the A C Camargo Cancer Center (A C Camargo Biobank), Brazilian National Tumor and DNA Bank (BNT-INCA), and Banco de Tumores Ricardo Renzo Brentani.

Reasons to subscribe to Brazil biobank market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Brazil biobank market databook

  • Our clientele includes a mix of biobank market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Brazil biobank market , including forecasts for subscribers. This country databook contains high-level insights into Brazil biobank market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Brazil biobank market size, by product & services, 2021-2033 (US$M)

Brazil Biobank Market Outlook Share, 2025 & 2033 (US$M)

Brazil biobank market size, by product & services, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online